Latest KFF Health News Content

Latest KFF Health News Stories

Mylan Reports 2 Federal Probes On Prices, Third-Quarter Loss After EpiPen Settlement

Morning Briefing

The company says the Securities and Exchange Commission is investigating its Medicaid rebates for the EpiPen while the Justice Department is looking into “marketing, pricing and sale” of generic medicines.

FDA Mulls Plan For How Tweets Promoting Prescriptions Drugs Should Inform About Side Effects

Morning Briefing

The Food and Drug Administration also issues a rule aimed at curbing the use of citizen petitions for generic drugs or biosimilars. Some agency officials say the practice is used to slow down the approvals process.

Backlash To Gutting Medicaid Could Complicate Promises To Dismantle ACA

Morning Briefing

Both Donald Trump and congressional Republicans want to shift Medicaid into a block-grant program, but that could mean many who received much-needed coverage under the health may lose their insurance.

Trump Likely To Target Vulnerable Pillars Of Health Law, But Portions May Be Here To Stay

Morning Briefing

Republican leaders say they are going to “hit the ground running” to start dismantling what they can of the Affordable Care Act. But after six years, there are aspects of the law now baked into the industry that won’t be easy to upend.

California Lends Its Weight To Wider Marijuana Acceptance

KFF Health News Original

The number of states with laws permitting marijuana use underscores a national cultural shift toward wider acceptance of the drug, despite the federal ban and limited evidence on the public health impacts of legalization.